TreeHouse Foods Acquisition Sends Shares Higher

TreeHouse Foods acquisition by Investindustrial includes a $22.50 cash price and CVR, spurring a surge and raising a fairness probe before a Q1 2026 close.

November 10, 2025·2 min read
View all news articles
Outlined approval seal on a solid emerald-green background evoking the TreeHouse Foods acquisition and probe.

KEY TAKEAWAYS

  • Investindustrial agreed to buy TreeHouse for $22.50 per share plus one nontransferable CVR, valuing it at $2.9 billion.
  • The all-cash deal is not subject to a financing condition and has unanimous board support and JANA backing.
  • A Halper Sadeh fairness probe and uncertain CVR payout complicate shareholder approval before an expected Q1 2026 close.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

TreeHouse Foods, Inc. (NYSE: THS) agreed to be acquired by Investindustrial on Nov. 10, 2025, in a board-approved transaction. The announcement sent shares higher despite a shareholder fairness probe by Halper Sadeh LLC and the company’s withdrawal of guidance amid the pending deal.

Deal Terms, Backing, and Financial Results

Investindustrial, through Industrial F&B Investments III Inc., will acquire TreeHouse Foods for $22.50 per share in cash plus one non-transferable contingent-value right (CVR) per share. The transaction values the company at a $2.9 billion enterprise value and about $1.2 billion in equity. The CVR entitles holders to 85% of net proceeds, if any, from ongoing litigation related to TreeHouse’s coffee business, though the timing and amount of any payout remain uncertain. The all-cash deal, which is not subject to a financing condition, represents a 38.0% premium to TreeHouse’s Sept. 26 closing price and about 29.0% above the 30-day volume-weighted average before deal speculation.

The board unanimously approved the buyout, and JANA Partners, a roughly 10% shareholder, has agreed to vote in favor. The transaction is expected to close in the first quarter of 2026, pending shareholder and regulatory approvals and customary closing conditions.

TreeHouse reported third-quarter 2025 net sales of $840 million, up 0.1% year over year, but posted a net loss of $266 million that included a $290 million non-cash goodwill impairment. Adjusted earnings per share fell to $0.43 from $0.74 a year earlier, and adjusted EBITDA declined to $92 million from $103 million. The company withdrew its guidance due to the pending acquisition.

The fairness of the sale is under investigation by Halper Sadeh LLC, which is reviewing whether the transaction terms serve TreeHouse shareholders.

Chairman Steve Oakland said the agreement with Investindustrial "will provide shareholders with immediate cash value, at a substantial premium."

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Roku Q1 Earnings Raise Revenue Forecast

Roku Q1 Earnings Raise Revenue Forecast

Roku Q1 earnings showed accelerating ad and subscription momentum and drove management to raise the platform revenue forecast, likely lifting trading flows.

Rolls-Royce Keeps FY2026 Guidance Despite Mideast Risk

Rolls-Royce Keeps FY2026 Guidance Despite Mideast Risk

Rolls-Royce FY2026 guidance held after an April 30 trading update; rising flying hours and divisional order strength underpinned profit and cash targets.

Microsoft Q3 2026 Earnings Show AI Cloud Momentum

Microsoft Q3 2026 Earnings Show AI Cloud Momentum

Microsoft Q3 2026 earnings show a $37.0 billion AI run rate and robust Azure demand, prompting traders to shift into AI infrastructure and cloud exposure.

Roblox Cuts Guidance Amid Safety Costs

Roblox Cuts Guidance Amid Safety Costs

Roblox cuts guidance as safety initiatives and a legal settlement curb near-term user growth; Q1 showed revenue and bookings gains but outlook was trimmed.

Amgen Q1 Results: Tavneos Update as Sales Rise

Amgen Q1 Results: Tavneos Update as Sales Rise

Amgen Q1 results showed stronger sales and an EPS beat that lifted FY2026 guidance and may shift positioning amid a Tavneos FDA withdrawal proposal.

Reddit Q1 Results Beat Estimates

Reddit Q1 Results Beat Estimates

Reddit Q1 results delivered a top-line beat led by surging ad revenue and stronger Q2 revenue guidance that should shape near-term trader positioning.